• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿病细胞模型中编码和非编码基因的转录失调。

Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease.

机构信息

Department of Neuroscience, Institute of Psychiatry, King's College London, CCBB, London SE5 9JU, UK.

出版信息

Biochem Soc Trans. 2009 Dec;37(Pt 6):1270-5. doi: 10.1042/BST0371270.

DOI:10.1042/BST0371270
PMID:19909260
Abstract

HD (Huntington's disease) is a late onset heritable neurodegenerative disorder that is characterized by neuronal dysfunction and death, particularly in the cerebral cortex and medium spiny neurons of the striatum. This is followed by progressive chorea, dementia and emotional dysfunction, eventually resulting in death. HD is caused by an expanded CAG repeat in the first exon of the HD gene that results in an abnormally elongated polyQ (polyglutamine) tract in its protein product, Htt (Huntingtin). Wild-type Htt is largely cytoplasmic; however, in HD, proteolytic N-terminal fragments of Htt form insoluble deposits in both the cytoplasm and nucleus, provoking the idea that mutHtt (mutant Htt) causes transcriptional dysfunction. While a number of specific transcription factors and co-factors have been proposed as mediators of mutHtt toxicity, the causal relationship between these Htt/transcription factor interactions and HD pathology remains unknown. Previous work has highlighted REST [RE1 (repressor element 1)-silencing transcription factor] as one such transcription factor. REST is a master regulator of neuronal genes, repressing their expression. Many of its direct target genes are known or suspected to have a role in HD pathogenesis, including BDNF (brain-derived neurotrophic factor). Recent evidence has also shown that REST regulates transcription of regulatory miRNAs (microRNAs), many of which are known to regulate neuronal gene expression and are dysregulated in HD. Thus repression of miRNAs constitutes a second, indirect mechanism by which REST can alter the neuronal transcriptome in HD. We will describe the evidence that disruption to the REST regulon brought about by a loss of interaction between REST and mutHtt may be a key contributory factor in the widespread dysregulation of gene expression in HD.

摘要

亨廷顿病(HD)是一种迟发性遗传性神经退行性疾病,其特征是神经元功能障碍和死亡,尤其是在大脑皮层和纹状体的中型多棘神经元中。随后是进行性舞蹈病、痴呆和情绪功能障碍,最终导致死亡。HD 是由 HD 基因第一外显子中 CAG 重复扩增引起的,导致其蛋白产物 Htt(亨廷顿蛋白)中异常延长的多聚 Q(多谷氨酰胺)链。野生型 Htt 主要存在于细胞质中;然而,在 HD 中,Htt 的蛋白酶切 N 端片段在细胞质和核内形成不溶性沉积物,这引发了一个想法,即 mutHtt(突变 Htt)导致转录功能障碍。虽然已经提出了许多特定的转录因子和共因子作为 mutHtt 毒性的介质,但这些 Htt/转录因子相互作用与 HD 病理学之间的因果关系仍不清楚。以前的工作强调了 REST [RE1(抑制元件 1)-沉默转录因子]作为这样的转录因子之一。REST 是神经元基因的主要调节因子,抑制其表达。其许多直接靶基因已知或怀疑在 HD 发病机制中起作用,包括 BDNF(脑源性神经营养因子)。最近的证据还表明,REST 调节调节性 miRNA(microRNA)的转录,其中许多已知调节神经元基因表达,并且在 HD 中失调。因此,miRNA 的抑制构成了 REST 在 HD 中改变神经元转录组的第二个间接机制。我们将描述证据表明,由于 REST 与 mutHtt 之间相互作用的丧失导致 REST 调节子的破坏,可能是 HD 中广泛的基因表达失调的一个关键促成因素。

相似文献

1
Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease.亨廷顿病细胞模型中编码和非编码基因的转录失调。
Biochem Soc Trans. 2009 Dec;37(Pt 6):1270-5. doi: 10.1042/BST0371270.
2
Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington's disease.在亨廷顿病的细胞模型中,REST 调节的编码和非编码 RNA 的失调。
J Neurochem. 2013 Feb;124(3):418-30. doi: 10.1111/jnc.12090.
3
Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington's disease.通过改良的 REST 诱饵寡核苷酸在亨廷顿病细胞模型中拯救基因表达。
J Neurochem. 2011 Feb;116(3):415-25. doi: 10.1111/j.1471-4159.2010.07122.x. Epub 2010 Dec 13.
4
Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington's disease models.小分子结合阻遏复合物 REST-mSIN3b 可恢复亨廷顿病模型中的神经元基因转录。
J Neurochem. 2013 Oct;127(1):22-35. doi: 10.1111/jnc.12348. Epub 2013 Jul 19.
5
Gene dysregulation in Huntington's disease: REST, microRNAs and beyond.亨廷顿舞蹈症中的基因失调:REST、微小RNA及其他。
Neuromolecular Med. 2009;11(3):183-99. doi: 10.1007/s12017-009-8063-4. Epub 2009 May 21.
6
Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease.在亨廷顿舞蹈病中,抑制元件1沉默转录因子/神经元限制性沉默因子在其靶基因上的占据情况受到广泛破坏。
J Neurosci. 2007 Jun 27;27(26):6972-83. doi: 10.1523/JNEUROSCI.4278-06.2007.
7
PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).PRMT5介导的对称精氨酸二甲基化受突变型亨廷顿蛋白抑制,并在亨廷顿舞蹈病(HD)中受损。
Cell Cycle. 2015;14(11):1716-29. doi: 10.1080/15384101.2015.1033595.
8
Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.特定的半胱天冬酶相互作用和放大参与亨廷顿舞蹈病中的选择性神经元易损性。
Cell Death Differ. 2004 Apr;11(4):424-38. doi: 10.1038/sj.cdd.4401358.
9
Inhibition of apoptosis signal-regulating kinase 1 reduces endoplasmic reticulum stress and nuclear huntingtin fragments in a mouse model of Huntington disease.抑制凋亡信号调节激酶 1 可减少亨廷顿病小鼠模型中的内质网应激和核内亨廷顿蛋白片段。
Neuroscience. 2009 Nov 10;163(4):1128-34. doi: 10.1016/j.neuroscience.2009.07.048. Epub 2009 Jul 28.
10
The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.亨廷顿舞蹈症细胞模型中早期转录变化和聚集体形成的动力学
BMC Genomics. 2017 May 12;18(1):373. doi: 10.1186/s12864-017-3745-z.

引用本文的文献

1
The Role of Brain-Derived Neurotrophic Factor as an Essential Mediator in Neuronal Functions and the Therapeutic Potential of Its Mimetics for Neuroprotection in Neurologic and Psychiatric Disorders.脑源性神经营养因子作为神经元功能的重要介导因子的作用及其模拟物在神经和精神疾病神经保护中的治疗潜力。
Molecules. 2025 Feb 12;30(4):848. doi: 10.3390/molecules30040848.
2
Transcriptome Study in Sicilian Patients with Huntington's Disease.西西里岛亨廷顿舞蹈病患者的转录组研究。
Diagnostics (Basel). 2025 Feb 7;15(4):409. doi: 10.3390/diagnostics15040409.
3
The role of microRNAs in neurodegenerative diseases: a review.
微小 RNA 在神经退行性疾病中的作用:综述。
Cell Biol Toxicol. 2023 Feb;39(1):53-83. doi: 10.1007/s10565-022-09761-x. Epub 2022 Sep 20.
4
A Review of Molecular Interplay between Neurotrophins and miRNAs in Neuropsychological Disorders.神经递质与 microRNAs 在神经心理障碍中的分子相互作用综述。
Mol Neurobiol. 2022 Oct;59(10):6260-6280. doi: 10.1007/s12035-022-02966-5. Epub 2022 Aug 2.
5
A Mechanistic Theory of Development-Aging Continuity in Humans and Other Mammals.人类和其他哺乳动物的发育-衰老连续性的机制理论。
Cells. 2022 Mar 7;11(5):917. doi: 10.3390/cells11050917.
6
Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics.亨廷顿病中的线粒体异常与突触损伤:聚焦于有缺陷的线粒体自噬及线粒体靶向治疗
Mol Neurobiol. 2021 Dec;58(12):6350-6377. doi: 10.1007/s12035-021-02556-x. Epub 2021 Sep 14.
7
Difference of binding modes among three ligands to a receptor mSin3B corresponding to their inhibitory activities.三种配体与受体 mSin3B 结合模式的差异与其抑制活性相对应。
Sci Rep. 2021 Mar 17;11(1):6178. doi: 10.1038/s41598-021-85612-9.
8
The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke.脑源性神经营养因子与神经退行性疾病和缺血性脑卒中相关 microRNAs 的关系。
Mol Neurobiol. 2021 Jan;58(1):329-347. doi: 10.1007/s12035-020-02101-2. Epub 2020 Sep 17.
9
Sertraline, chlorprothixene, and chlorpromazine characteristically interact with the REST-binding site of the corepressor mSin3, showing medulloblastoma cell growth inhibitory activities.舍曲林、氯普噻吨和氯丙嗪的特征在于与核心抑制物 mSin3 的 REST 结合位点相互作用,表现出神经母细胞瘤细胞生长抑制活性。
Sci Rep. 2018 Sep 13;8(1):13763. doi: 10.1038/s41598-018-31852-1.
10
Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease.发育过程中亨廷顿蛋白缺失的产后及成年期后果:对亨廷顿舞蹈症的启示
Neurobiol Dis. 2016 Dec;96:144-155. doi: 10.1016/j.nbd.2016.09.006. Epub 2016 Sep 10.